{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:59:58Z","timestamp":1792717198289,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Standard electrochemotherapy (ECT) is effective in many tumour types but is confined to\u00a0the treatment of small superficial lesions. Variable electrode-geometry ECT (VEG-ECT) may overcome these limitations by using long freely-placeable electrodes. Patients with bulky or deep-seated soft-tissue malignancies not amenable to resection participated in a single-arm phase-2 study (ISRCTN.11667954) and received a single course of VEG-ECT with intravenous bleomycin (15,000 IU\/m<jats:sup>2<\/jats:sup>) and concomitant electric pulses applied through an adjustable electrode array. The primary outcome was radiologic complete response rate (CRR) per RECIST; secondary endpoints included feasibility, metabolic response, toxicity (CTCAE), local progression-free survival (LPFS) and patient perception (EQ-5D). During 2009\u20132014, we enrolled 30 patients with trunk\/limb sarcomas, melanoma, Merkel-cell carcinoma, and colorectal\/lung cancer. Median tumour size was 4.7\u2009cm. Electrode probes were placed under US\/TC guidance (28 and 2 patients, respectively). Median procedure duration was 80\u2009minutes. Tumour coverage rate was 97% (29 of\u00a030 patients). Perioperative side-effects were negligible; one patient experienced grade-3 ulceration and infection. One-month <jats:sup>18<\/jats:sup>F-FDG-SUV decreased by 86%; CRR was 63% (95% CI 44\u201379%). Local control was durable in 24 of\u00a030 patients (two-year LPFS, 62%). Patients reported an improvement in \u201cusual\u00a0activities\u201d, \u201canxiety\/depression\u201d, and \u201coverall\u00a0health\u201d scores. VEG-ECT demonstrated encouraging antitumour activity in soft-tissue malignancies; a single course of treatment produced high and durable responses, with low complications.<\/jats:p>","DOI":"10.1038\/s41598-020-59230-w","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T11:02:57Z","timestamp":1581332577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Ablation of soft tissue tumours by long needle variable electrode-geometry electrochemotherapy: final report from a single-arm, single-centre phase-2 study"],"prefix":"10.1038","volume":"10","author":[{"given":"Andrea","family":"Simioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Valpione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Granziera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Riccardo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cavallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Sieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Stramare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Giovanni","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"59230_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10434-000-0526-7","volume":"7","author":"TA Damron","year":"2000","unstructured":"Damron, T. A. & Heiner, J. Distant soft tissue metastases: a series of 30 new patients and 91 cases from the literature. Ann. Surg. Oncol. 7, 526\u2013534 (2000).","journal-title":"Ann. Surg. Oncol."},{"key":"59230_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/cncr.23151","volume":"112","author":"JA Plaza","year":"2008","unstructured":"Plaza, J. A., Perez-Montiel, D., Mayerson, J., Morrison, C. & Suster, S. Metastases to soft tissue: a review of 118 cases over a 30-year period. Cancer. 112, 193\u2013203 (2008).","journal-title":"Cancer."},{"key":"59230_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11864-002-0069-1","volume":"3","author":"EK Abdalla","year":"2002","unstructured":"Abdalla, E. K. & Pisters, P. W. T. Metastasectomy for limited metastases from soft tissue sarcoma. Curr. Treat. Options Oncol. 3, 497\u2013505 (2002).","journal-title":"Curr. Treat. Options Oncol."},{"key":"59230_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.tvir.2013.08.007","volume":"16","author":"A Nicholas Kurup","year":"2013","unstructured":"Nicholas Kurup, A. & Callstrom, M. R. Ablation of musculoskeletal metastases: pain palliation, fracture risk reduction, and oligometastatic disease. Tech. Vasc. Interv. Radiol. 16, 253\u2013261 (2013).","journal-title":"Tech. Vasc. Interv. Radiol."},{"key":"59230_CR5","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.14694\/EDBK_157450","volume":"35","author":"A Gronchi","year":"2016","unstructured":"Gronchi, A., Guadagnolo, B. A. & Erinjeri, J. P. Local ablative therapies to metastatic soft tissue sarcoma. Am. Soc. Clin. Oncol. Educ. B. 35, e566\u2013575 (2016).","journal-title":"Am. Soc. Clin. Oncol. Educ. B."},{"key":"59230_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1158\/2326-6066.CIR-15-0156","volume":"4","author":"S Theurich","year":"2016","unstructured":"Theurich, S. et al. Local tumor treatment in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma. Cancer Immunol. Res. 4, 744\u2013754 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"59230_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2478\/raon-2014-0035","volume":"49","author":"S Valpione","year":"2015","unstructured":"Valpione, S., Campana, L. G., Pigozzo, J. & Chiarion-Sileni, V. Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib. Radiol. Oncol. 49, 71\u201374 (2015).","journal-title":"Radiol. Oncol."},{"key":"59230_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1053\/j.seminoncol.2019.04.002","volume":"46","author":"LG Campana","year":"2019","unstructured":"Campana, L. G. et al. Electrochemotherapy of superficial tumors \u2013 Current status: basic principles, operating procedures, shared indications, and emerging applications. Semin. Oncol. 46, 173\u2013191 (2019).","journal-title":"Semin. Oncol."},{"key":"59230_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1586\/era.10.43","volume":"10","author":"T Jarm","year":"2010","unstructured":"Jarm, T., Cemazar, M., Miklavcic, D. & Sersa, G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev. Anticancer Ther. 10, 729\u2013746 (2010).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"59230_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/jso.23481","volume":"109","author":"N Solari","year":"2014","unstructured":"Solari, N. et al. Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent. J. Surg. Oncol. 109, 270\u2013274 (2014).","journal-title":"J. Surg. Oncol."},{"key":"59230_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2478\/raon-2013-0002","volume":"47","author":"B Mali","year":"2013","unstructured":"Mali, B. et al. Tumor size and effectiveness of electrochemotherapy. Radiol. Oncol. 47, 32\u201341 (2013).","journal-title":"Radiol. Oncol."},{"key":"59230_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00268-013-2321-1","volume":"38","author":"LG Campana","year":"2014","unstructured":"Campana, L. G. et al. Electrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: results of a non-comparative phase II study. World J. Surg. 38, 813\u2013822 (2014).","journal-title":"World J. Surg."},{"key":"59230_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/jso.23625","volume":"110","author":"I Edhemovic","year":"2014","unstructured":"Edhemovic, I. et al. Intraoperative electrochemotherapy of colorectal liver metastases. J. Surg. Oncol. 110, 320\u2013327 (2014).","journal-title":"J. Surg. Oncol."},{"key":"59230_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejso.2018.11.023","volume":"45","author":"LG Campana","year":"2019","unstructured":"Campana, L. G. et al. Electrochemotherapy \u2013 Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur. J. Surg. Oncol. 45, 92\u2013102 (2019).","journal-title":"Eur. J. Surg. Oncol."},{"key":"59230_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1475-925X-9-10","volume":"9","author":"D Miklavcic","year":"2010","unstructured":"Miklavcic, D. et al. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed. Eng. Online. 9, 10 (2010).","journal-title":"Biomed. Eng. Online."},{"key":"59230_CR16","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1007\/s00268-016-3627-6","volume":"40","author":"G Bianchi","year":"2016","unstructured":"Bianchi, G., Campanacci, L., Ronchetti, M. & Donati, D. Electrochemotherapy in the treatment of bone metastases: a phase II trial. World J. Surg. 40, 3088\u20133094 (2016).","journal-title":"World J. Surg."},{"key":"59230_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.talanta.2016.06.062","volume":"160","author":"T Kosjek","year":"2016","unstructured":"Kosjek, T. et al. Identification and quantification of bleomycin in serum and tumor tissue by liquid chromatography coupled to high-resolution mass spectrometry. Talanta. 160, 164\u2013171 (2016).","journal-title":"Talanta."},{"key":"59230_CR18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/sim.721","volume":"20","author":"RP A\u2019Hern","year":"2001","unstructured":"A\u2019Hern, R. P. Sample size tables for exact single-stage phase II designs. Stat. Med. 20, 859\u2013866 (2001).","journal-title":"Stat. Med."},{"key":"59230_CR19","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1302\/0301-620X.91B8.21680","volume":"91","author":"R Abed","year":"2009","unstructured":"Abed, R., Grimer, R. J., Carter, S. R., Tillman, R. M. & Abudu, A. J. L. Soft-tissue metastases: their presentation and origin. J. Bone Jt. Surg Br. 91, 1083\u20131085 (2009).","journal-title":"J. Bone Jt. Surg Br."},{"key":"59230_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/(SICI)1096-9098(199810)69:2<94::AID-JSO9>3.0.CO;2-4","volume":"69","author":"UNM Rao","year":"1998","unstructured":"Rao, U. N. M., Hanan, S. H., Lotze, M. T. & Karakousis, C. P. Distant skin and soft tissue metastases from sarcomas. J. Surg. Oncol. 69, 94\u201398 (1998).","journal-title":"J. Surg. Oncol."},{"key":"59230_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ctrv.2008.05.003","volume":"34","author":"SR Martinez","year":"2008","unstructured":"Martinez, S. R. & Young, S. E. A rational surgical approach to the treatment of distant melanoma metastases. Cancer Treat. Rev. 34, 14\u201320 (2008).","journal-title":"Cancer Treat. Rev."},{"key":"59230_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/archsurg.139.9.961","volume":"139","author":"R Essner","year":"2004","unstructured":"Essner, R. et al. Contemporary surgical treatment of advanced-stage melanoma. Arch. Surg. 139, 961\u2013966 (2004).","journal-title":"Arch. Surg."},{"key":"59230_CR23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/CMR.0000000000000466","volume":"28","author":"N G\u00f3mez-Le\u00f3n","year":"2018","unstructured":"G\u00f3mez-Le\u00f3n, N. et al. Skeletal muscle and solitary bone metastases from malignant melanoma: multimodality imaging and oncological outcome. Melanoma Res. 28, 562\u2013570 (2018).","journal-title":"Melanoma Res."},{"key":"59230_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2342-7-8","volume":"7","author":"NC Nguyen","year":"2007","unstructured":"Nguyen, N. C., Chaar, B. T. & Osman, M. M. Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET\/CT. BMC Med. Imaging. 7, 8 (2007).","journal-title":"BMC Med. Imaging."},{"key":"59230_CR25","doi-asserted-by":"publisher","first-page":"iv51","DOI":"10.1093\/annonc\/mdy096","volume":"29","author":"PG Casali","year":"2018","unstructured":"Casali, P. G. et al. Soft tissue and visceral sarcomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 29, iv51\u201367 (2018).","journal-title":"Ann. Oncol."},{"key":"59230_CR26","doi-asserted-by":"crossref","unstructured":"Soyfer, V. et al. Radiation therapy for palliation of sarcoma metastases: a unique and uniform hypofractionation experience. Sarcoma. 2010, 927972 (2010).","DOI":"10.1155\/2010\/927972"},{"key":"59230_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/jso.20297","volume":"91","author":"RB Takkenberg","year":"2005","unstructured":"Takkenberg, R. B. et al. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients. J. Surg. Oncol. 91, 107\u2013111 (2005).","journal-title":"J. Surg. Oncol."},{"key":"59230_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1245\/s10434-009-0326-7","volume":"16","author":"HM Kroon","year":"2009","unstructured":"Kroon, H. M., Lin, D. Y., Kam, P. C. A. & Thompson, J. F. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma. Ann. Surg. Oncol. 16, 1193\u20131201 (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"59230_CR29","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ctrv.2015.05.009","volume":"41","author":"NR Datta","year":"2015","unstructured":"Datta, N. R. et al. Local hyperthermia combined with radiotherapy and-\/or chemotherapy: recent advances and promises for the future. Cancer Treat. Rev. 41, 742\u2013753 (2015).","journal-title":"Cancer Treat. Rev."},{"key":"59230_CR30","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/sj.bjc.6601320","volume":"89","author":"P Radny","year":"2003","unstructured":"Radny, P. et al. Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. Br. J. Cancer. 89, 1620\u20131626 (2003).","journal-title":"Br. J. Cancer."},{"key":"59230_CR31","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1200\/JCO.2010.33.0902","volume":"29","author":"RE Neal","year":"2011","unstructured":"Neal, R. E. et al. Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J. Clin. Oncol. 29, e372\u2013377 (2011).","journal-title":"J. Clin. Oncol."},{"key":"59230_CR32","doi-asserted-by":"publisher","first-page":"e76260","DOI":"10.1371\/journal.pone.0076260","volume":"8","author":"P Philips","year":"2013","unstructured":"Philips, P., Hays, D. & Martin, R. C. G. Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated. PLoS One. 8, e76260 (2013).","journal-title":"PLoS One."},{"key":"59230_CR33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1200\/EDBK_200573","volume":"38","author":"JE Grilley-Olson","year":"2018","unstructured":"Grilley-Olson, J. E., Webber, N. P., Demos, D. S., Christensen, J. D. & Kirsch, D. G. Multidisciplinary management of oligometastatic soft tissue sarcoma. Am. Soc. Clin. Oncol. Educ. B. 38, 939\u2013948 (2018).","journal-title":"Am. Soc. Clin. Oncol. Educ. B."},{"key":"59230_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s10585-013-9601-x","volume":"30","author":"M Fini","year":"2013","unstructured":"Fini, M. et al. Electrochemotherapy is effective in the treatment of rat bone metastases. Clin. Exp. Metastasis. 30, 1033\u20131045 (2013).","journal-title":"Clin. Exp. Metastasis."},{"key":"59230_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40395-y","volume":"9","author":"J Zmuc","year":"2019","unstructured":"Zmuc, J. et al. Large liver blood vessels and bile ducts are not damaged by electrochemotherapy with bleomycin in pigs. Sci. Rep. 9, 3649 (2019).","journal-title":"Sci. Rep."},{"key":"59230_CR36","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/S0006-3495(98)77924-X","volume":"74","author":"D Miklav\u010di\u010d","year":"1998","unstructured":"Miklav\u010di\u010d, D. et al. The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys. J. 74, 2152\u20132158 (1998).","journal-title":"Biophys. J."},{"key":"59230_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s11517-015-1368-6","volume":"54","author":"LG Campana","year":"2016","unstructured":"Campana, L. G. et al. Electrical resistance of human soft tissue sarcomas: an ex vivo study on surgical specimens. Med. Biol. Eng. Comput. 54, 773\u2013787 (2016).","journal-title":"Med. Biol. Eng. Comput."},{"key":"59230_CR38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2478\/raon-2018-0041","volume":"52","author":"N Boc","year":"2018","unstructured":"Boc, N. et al. Ultrasonographic changes in the liver tumors as indicators of adequate tumor coverage with electric field for effective electrochemotherapy. Radiol. Oncol. 52, 383\u2013391 (2018).","journal-title":"Radiol. Oncol."},{"key":"59230_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10846-5","volume":"7","author":"M Kranjc","year":"2017","unstructured":"Kranjc, M. et al. Predicting irreversible electroporation-induced tissue damage by means of magnetic resonance electrical impedance tomography. Sci. Rep. 7, 10323 (2017).","journal-title":"Sci. Rep."},{"key":"59230_CR40","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2217\/fon-2017-0565","volume":"14","author":"A Sebio","year":"2018","unstructured":"Sebio, A., Wilky, B. A., Keedy, V. L. & Jones, R. L. The current landscape of early drug development for patients with sarcoma in the immunotherapy era. Future Oncol. 14, 1197\u20131211 (2018).","journal-title":"Future Oncol."},{"key":"59230_CR41","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00262-010-0957-3","volume":"60","author":"B Weide","year":"2011","unstructured":"Weide, B. et al. Survival after intratumoral interleukin-2 treatment of 72 melanoma patients and response upon the first chemotherapy during follow-up. Cancer Immunol. Immunother. 60, 487\u2013493 (2011).","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59230-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59230-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59230-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:30:24Z","timestamp":1670308224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59230-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59230"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59230-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"10 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant interests to disclose. The disposable material used during the procedures was provided by IGEA Spa, (Carpi, Modena, Italy), which nonetheless had no access to the study database nor participated in data analysis or the preparation of the manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2291"}}